Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Menal Bhandari

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of the Egyptian National Cancer Institute|September 4, 2016
Burden of preventable cancers in India: Time to strike the cancer epidemicAjeet Kumar Gandhi, Pavnesh Kumar, Menal Bhandari, et al.
Journal of Clinical and Diagnostic Research : JCDR|June 30, 2017
Comparative Study of Adjuvant Temozolomide Six Cycles Versus Extended 12 Cycles in Newly Diagnosed Glioblastoma MultiformeMenal Bhandari, Ajeet Kumar Gandhi, Bharti Devnani, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 31, 2024
A sample size analysis of a mathematical model of longitudinal tumor volume and progression-free survival for Bayesian individual dynamic predictions in recurrent high-grade gliomaDaniel J Glazar, Solmaz Sahebjam, Hsiang-Husan M Yu, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|August 28, 2017
Current Trends in Management of Oral Mucositis in Cancer TreatmentAbhishek Shankar, Shubham Roy, Menal Bhandari, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 21, 2016
Change in Trend in Various Clinico-Pathological Factors and Treatment Profile of Breast Cancer Patients: a Tertiary Cancer Centre ExperienceAbhishek Shankar, Shubham Roy, Gk Rath, et al.
Cancers|February 13, 2026
The Optimal Management of Patients with Prostate Cancer with Oligometastatic Disease and Low Metastatic Burden in the PSMA-PET EraMenal Bhandari, Isaac Lasko, Jacob Pozin, et al.
Seminars in Radiation Oncology|June 14, 2025
The Evolving Management of Radiorecurrent Prostate CancerJacob Pozin, Menal Bhandari, Luca Valle, et al.
JTO Clinical and Research Reports|May 9, 2023
Magnetic Resonance-Guided Stereotactic Body Radiation Therapy/Hypofractionated Radiation therapy for Metastatic and Primary Central and Ultracentral Lung LesionsMaria L Sandoval, Austin J Sim, John M Bryant, et al.
Current Issues in Molecular Biology|January 30, 2026
Prophylactic Cranial Irradiation in Small Cell Lung Cancer: Evolution of Evidence, Current Status, and Future DirectionsSwati Mamidanna, Menal Bhandari, Charvi Shah, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 2023
Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastasesAmmoren E Dohm, Justyn Y Nakashima, Hruday Kalagotla, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of the Egyptian National Cancer Institute|September 4, 2016
Burden of preventable cancers in India: Time to strike the cancer epidemicAjeet Kumar Gandhi, Pavnesh Kumar, Menal Bhandari, et al.
Journal of Clinical and Diagnostic Research : JCDR|June 30, 2017
Comparative Study of Adjuvant Temozolomide Six Cycles Versus Extended 12 Cycles in Newly Diagnosed Glioblastoma MultiformeMenal Bhandari, Ajeet Kumar Gandhi, Bharti Devnani, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 31, 2024
A sample size analysis of a mathematical model of longitudinal tumor volume and progression-free survival for Bayesian individual dynamic predictions in recurrent high-grade gliomaDaniel J Glazar, Solmaz Sahebjam, Hsiang-Husan M Yu, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|August 28, 2017
Current Trends in Management of Oral Mucositis in Cancer TreatmentAbhishek Shankar, Shubham Roy, Menal Bhandari, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 21, 2016
Change in Trend in Various Clinico-Pathological Factors and Treatment Profile of Breast Cancer Patients: a Tertiary Cancer Centre ExperienceAbhishek Shankar, Shubham Roy, Gk Rath, et al.
Cancers|February 13, 2026
The Optimal Management of Patients with Prostate Cancer with Oligometastatic Disease and Low Metastatic Burden in the PSMA-PET EraMenal Bhandari, Isaac Lasko, Jacob Pozin, et al.
Seminars in Radiation Oncology|June 14, 2025
The Evolving Management of Radiorecurrent Prostate CancerJacob Pozin, Menal Bhandari, Luca Valle, et al.
JTO Clinical and Research Reports|May 9, 2023
Magnetic Resonance-Guided Stereotactic Body Radiation Therapy/Hypofractionated Radiation therapy for Metastatic and Primary Central and Ultracentral Lung LesionsMaria L Sandoval, Austin J Sim, John M Bryant, et al.
Current Issues in Molecular Biology|January 30, 2026
Prophylactic Cranial Irradiation in Small Cell Lung Cancer: Evolution of Evidence, Current Status, and Future DirectionsSwati Mamidanna, Menal Bhandari, Charvi Shah, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 2023
Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastasesAmmoren E Dohm, Justyn Y Nakashima, Hruday Kalagotla, et al.
Pageof 2